173 related articles for article (PubMed ID: 16570270)
1. KIF14 mRNA expression is a predictor of grade and outcome in breast cancer.
Corson TW; Gallie BL
Int J Cancer; 2006 Sep; 119(5):1088-94. PubMed ID: 16570270
[TBL] [Abstract][Full Text] [Related]
2. KIF14 is a candidate oncogene in the 1q minimal region of genomic gain in multiple cancers.
Corson TW; Huang A; Tsao MS; Gallie BL
Oncogene; 2005 Jul; 24(30):4741-53. PubMed ID: 15897902
[TBL] [Abstract][Full Text] [Related]
3. Kinesin family member 14: an independent prognostic marker and potential therapeutic target for ovarian cancer.
Thériault BL; Pajovic S; Bernardini MQ; Shaw PA; Gallie BL
Int J Cancer; 2012 Apr; 130(8):1844-54. PubMed ID: 21618518
[TBL] [Abstract][Full Text] [Related]
4. Kinesin family member 14 is a candidate prognostic marker for outcome of glioma patients.
Wang Q; Wang L; Li D; Deng J; Zhao Z; He S; Zhang Y; Tu Y
Cancer Epidemiol; 2013 Feb; 37(1):79-84. PubMed ID: 22999822
[TBL] [Abstract][Full Text] [Related]
5. KIF14 messenger RNA expression is independently prognostic for outcome in lung cancer.
Corson TW; Zhu CQ; Lau SK; Shepherd FA; Tsao MS; Gallie BL
Clin Cancer Res; 2007 Jun; 13(11):3229-34. PubMed ID: 17545527
[TBL] [Abstract][Full Text] [Related]
6. High expression of KIF14 in retinoblastoma: association with older age at diagnosis.
Madhavan J; Coral K; Mallikarjuna K; Corson TW; Amit N; Khetan V; George R; Biswas J; Gallie BL; Kumaramanickavel G
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):4901-6. PubMed ID: 17962437
[TBL] [Abstract][Full Text] [Related]
7. A targeted RNAi screen of the breast cancer genome identifies KIF14 and TLN1 as genes that modulate docetaxel chemosensitivity in triple-negative breast cancer.
Singel SM; Cornelius C; Batten K; Fasciani G; Wright WE; Lum L; Shay JW
Clin Cancer Res; 2013 Apr; 19(8):2061-70. PubMed ID: 23479679
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation of KIF14 is a predictor of poor survival and a novel prognostic biomarker of chemoresistance to paclitaxel treatment in cervical cancer.
Wang W; Shi Y; Li J; Cui W; Yang B
Biosci Rep; 2016; 36(2):. PubMed ID: 27128470
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of a novel candidate oncogene KIF14 correlates with tumor progression and poor prognosis in prostate cancer.
Zhang Y; Yuan Y; Liang P; Zhang Z; Guo X; Xia L; Zhao Y; Shu XS; Sun S; Ying Y; Cheng Y
Oncotarget; 2017 Jul; 8(28):45459-45469. PubMed ID: 28525372
[TBL] [Abstract][Full Text] [Related]
10. KIF14 promotes cell proliferation via activation of Akt and is directly targeted by miR-200c in colorectal cancer.
Wang ZZ; Yang J; Jiang BH; Di JB; Gao P; Peng L; Su XQ
Int J Oncol; 2018 Nov; 53(5):1939-1952. PubMed ID: 30226594
[TBL] [Abstract][Full Text] [Related]
11. The kinesin KIF14 is overexpressed in medulloblastoma and downregulation of KIF14 suppressed tumor proliferation and induced apoptosis.
Li KK; Qi Y; Xia T; Chan AK; Zhang ZY; Aibaidula A; Zhang R; Zhou L; Yao Y; Ng HK
Lab Invest; 2017 Aug; 97(8):946-961. PubMed ID: 28504687
[TBL] [Abstract][Full Text] [Related]
12. Nup88 mRNA overexpression is associated with high aggressiveness of breast cancer.
Agudo D; Gómez-Esquer F; Martínez-Arribas F; Núñez-Villar MJ; Pollán M; Schneider J
Int J Cancer; 2004 May; 109(5):717-20. PubMed ID: 14999780
[TBL] [Abstract][Full Text] [Related]
13. KIF14 promotes tumor progression and metastasis and is an independent predictor of poor prognosis in human gastric cancer.
Yang Z; Li C; Yan C; Li J; Yan M; Liu B; Zhu Z; Wu Y; Gu Q
Biochim Biophys Acta Mol Basis Dis; 2019 Jan; 1865(1):181-192. PubMed ID: 30404039
[TBL] [Abstract][Full Text] [Related]
14. KIF14 and E2F3 mRNA expression in human retinoblastoma and its phenotype association.
Madhavan J; Mitra M; Mallikarjuna K; Pranav O; Srinivasan R; Nagpal A; Venkatesan P; Kumaramanickavel G
Mol Vis; 2009; 15():235-40. PubMed ID: 19190782
[TBL] [Abstract][Full Text] [Related]
15. Expression and splicing of the unfolded protein response gene XBP-1 are significantly associated with clinical outcome of endocrine-treated breast cancer.
Davies MP; Barraclough DL; Stewart C; Joyce KA; Eccles RM; Barraclough R; Rudland PS; Sibson DR
Int J Cancer; 2008 Jul; 123(1):85-8. PubMed ID: 18386815
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of maspin mRNA expression in ER alpha-positive postmenopausal breast carcinomas.
Bièche I; Girault I; Sabourin JC; Tozlu S; Driouch K; Vidaud M; Lidereau R
Br J Cancer; 2003 Mar; 88(6):863-70. PubMed ID: 12644823
[TBL] [Abstract][Full Text] [Related]
17. The motor protein KIF14 inhibits tumor growth and cancer metastasis in lung adenocarcinoma.
Hung PF; Hong TM; Hsu YC; Chen HY; Chang YL; Wu CT; Chang GC; Jou YS; Pan SH; Yang PC
PLoS One; 2013; 8(4):e61664. PubMed ID: 23626713
[TBL] [Abstract][Full Text] [Related]
18. Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ.
Half E; Tang XM; Gwyn K; Sahin A; Wathen K; Sinicrope FA
Cancer Res; 2002 Mar; 62(6):1676-81. PubMed ID: 11912139
[TBL] [Abstract][Full Text] [Related]
19. KIF14 promotes AKT phosphorylation and contributes to chemoresistance in triple-negative breast cancer.
Singel SM; Cornelius C; Zaganjor E; Batten K; Sarode VR; Buckley DL; Peng Y; John GB; Li HC; Sadeghi N; Wright WE; Lum L; Corson TW; Shay JW
Neoplasia; 2014 Mar; 16(3):247-56, 256.e2. PubMed ID: 24784001
[TBL] [Abstract][Full Text] [Related]
20. High expression of KIF14 is associated with poor prognosis in patients with epithelial ovarian cancer.
Qiu HL; Deng SZ; Li C; Tian ZN; Song XQ; Yao GD; Geng JS
Eur Rev Med Pharmacol Sci; 2017 Jan; 21(2):239-245. PubMed ID: 28165566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]